RANITIDINE

RANITIDINE was reported 197836 times

RANITIDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYNOVIAL FLUID ANALYSIS 62 0.7126
1 COLORECTAL CANCER 17674 0.3699
2 HAEMATOPOIETIC NEOPLASM 69 0.3670
3 RENAL CANCER 16278 0.3413
4 OESOPHAGEAL CARCINOMA 9648 0.3250
5 HEPATIC CANCER 7592 0.3156
6 SMALL INTESTINE CARCINOMA 701 0.3141
7 HAEMOGLOBIN URINE PRESENT 62 0.3054
8 GASTRIC CANCER 7539 0.2973
9 BLADDER CANCER 16746 0.2841
10 PROSTATE CANCER 22252 0.2764
11 APPENDIX CANCER 250 0.2682
12 BREAST CANCER 24854 0.2664
13 GASTROINTESTINAL CARCINOMA 2362 0.2599
14 GALLBLADDER CANCER 373 0.2539
15 HAEMATOLOGICAL MALIGNANCY 705 0.2475
16 NASAL CAVITY CANCER 222 0.2421
17 PANCREATIC CARCINOMA 6840 0.2366
18 TESTIS CANCER 834 0.2131
19 UTERINE CANCER 1644 0.2046
20 CRYSTAL URINE PRESENT 111 0.1996
21 BRAIN NEOPLASM MALIGNANT 888 0.1985
22 THYROID CANCER 2299 0.1908
23 URINARY SEDIMENT PRESENT 117 0.1817
24 CERVIX CARCINOMA 652 0.1668
25 LUNG NEOPLASM MALIGNANT 6760 0.1643
26 URINE LEUKOCYTE ESTERASE POSITIVE 115 0.1643
27 TENOSYNOVITIS STENOSANS 87 0.1562
28 RENAL CANCER STAGE I 399 0.1523
29 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 256 0.1521
30 PROSTATIC DISORDER 837 0.1516
31 THROAT CANCER 633 0.1496
32 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I 140 0.1461
33 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE II 66 0.1432
34 RENAL CANCER STAGE III 260 0.1412
35 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 149 0.1403
36 RED BLOOD CELLS URINE POSITIVE 134 0.1386
37 COLORECTAL CANCER STAGE I 276 0.1317
38 RENAL CANCER STAGE II 233 0.1282
39 OVARIAN CANCER 1172 0.1270
40 BONE CANCER 527 0.1211
41 FACET JOINT SYNDROME 373 0.1145
42 NEPHROGENIC ANAEMIA 520 0.1121
43 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III 94 0.1112
44 BREAST CANCER STAGE III 714 0.1101
45 COLORECTAL CANCER STAGE II 308 0.1095
46 PROSTATE CANCER STAGE I 419 0.1094
47 HYPERPARATHYROIDISM SECONDARY 268 0.1069
48 LARYNGEAL CANCER 116 0.1042
49 BLADDER CANCER STAGE III 124 0.1025
50 BLADDER CANCER STAGE II 165 0.1024
51 PROSTATE CANCER STAGE II 310 0.1003
52 COLORECTAL CANCER STAGE III 495 0.0983
53 TEMPERATURE REGULATION DISORDER 219 0.0982
54 REBOUND ACID HYPERSECRETION 295 0.0974
55 BREAST CANCER STAGE I 898 0.0968
56 CLEAR CELL RENAL CELL CARCINOMA 67 0.0963
57 MONOCYTE PERCENTAGE INCREASED 67 0.0945
58 COLORECTAL CANCER STAGE IV 436 0.0944
59 GASTRIC CANCER STAGE II 70 0.0933
60 LYMPHOCYTE PERCENTAGE DECREASED 125 0.0930
61 GASTRIC CANCER STAGE III 76 0.0929
62 SKIN CANCER 1972 0.0915
63 PERIPHERAL VENOUS DISEASE 371 0.0908
64 PROSTATE CANCER STAGE III 238 0.0902
65 BLADDER CANCER STAGE IV 150 0.0896
66 NEUTROPHIL PERCENTAGE INCREASED 113 0.0895
67 PANCREATIC CARCINOMA STAGE III 62 0.0884
68 WHITE BLOOD CELLS URINE POSITIVE 166 0.0882
69 BREAST CANCER STAGE II 724 0.0869
70 RENAL CANCER STAGE IV 239 0.0869
71 HEPATIC CANCER STAGE IV 315 0.0850
72 SCHIZOAFFECTIVE DISORDER 149 0.0835
73 GASTRIC CANCER STAGE I 86 0.0816
74 TONSIL CANCER 65 0.0807
75 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 271 0.0804
76 PANCREATIC CARCINOMA STAGE IV 250 0.0792
77 ONYCHOMADESIS 330 0.0786
78 PROSTATE CANCER STAGE IV 268 0.0755
79 ANAL CANCER 72 0.0742
80 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 67 0.0723
81 BLEPHAROSPASM 444 0.0704
82 BREAST CANCER STAGE IV 185 0.0652
83 GASTRIC CANCER STAGE IV 138 0.0641
84 END STAGE RENAL DISEASE 1134 0.0621
85 RHEUMATIC FEVER 276 0.0619
86 CHRONIC KIDNEY DISEASE 4687 0.0616
87 BURSITIS 746 0.0614
88 BACTERIAL TEST POSITIVE 127 0.0569
89 ONYCHOMYCOSIS 239 0.0544
90 URINE ANALYSIS ABNORMAL 162 0.0541
91 DUODENAL ULCER PERFORATION 401 0.0539
92 URINE KETONE BODY PRESENT 85 0.0538
93 ALLERGY TO CHEMICALS 66 0.0530
94 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 371 0.0517
95 URINE ABNORMALITY 230 0.0505
96 CHRONIC SPONTANEOUS URTICARIA 58 0.0500
97 FINGER DEFORMITY 241 0.0497
98 NAIL DISORDER 423 0.0483
99 PLEURITIC PAIN 130 0.0471
100 MEAN CELL HAEMOGLOBIN DECREASED 86 0.0469
101 SCLERITIS 74 0.0462
102 HYPERCHOLESTEROLAEMIA 444 0.0459
103 COELIAC DISEASE 437 0.0445
104 HELICOBACTER INFECTION 456 0.0443
105 MUSCLE INJURY 359 0.0433
106 INCORRECT DOSE ADMINISTERED 9634 0.0422
107 BLOOD PRESSURE DIASTOLIC ABNORMAL 105 0.0412
108 FOLLICULITIS 428 0.0408
109 FOOD ALLERGY 315 0.0408
110 LIP DRY 362 0.0398
111 TOTAL LUNG CAPACITY DECREASED 63 0.0394
112 INJURY 2661 0.0378
113 RED CELL DISTRIBUTION WIDTH INCREASED 155 0.0373
114 COLON CANCER 551 0.0369
115 INFUSION SITE REACTION 110 0.0368
116 LIVE BIRTH 305 0.0364
117 BLOOD PRESSURE SYSTOLIC ABNORMAL 90 0.0364
118 ENDOMETRIAL CANCER 79 0.0359
119 C-REACTIVE PROTEIN ABNORMAL 227 0.0354
120 OBESITY 558 0.0350
121 JOINT RANGE OF MOTION DECREASED 462 0.0344
122 NEOPLASM MALIGNANT 2299 0.0344
123 PEMPHIGUS 430 0.0344
124 GRIP STRENGTH DECREASED 299 0.0339
125 HAND DEFORMITY 441 0.0336
126 WOUND INFECTION 360 0.0328
127 TUBULOINTERSTITIAL NEPHRITIS 610 0.0325
128 LEUKAEMIA 302 0.0320
129 CREPITATIONS 95 0.0319
130 CUSHINGOID 100 0.0311
131 DEFORMITY 284 0.0304
132 RENAL INJURY 901 0.0303
133 LYMPHOCYTE COUNT DECREASED 531 0.0300
134 BACK INJURY 326 0.0299
135 APLASTIC ANAEMIA 155 0.0296
136 LYMPHOMA 454 0.0293
137 DISLOCATION OF VERTEBRA 64 0.0280
138 GASTROOESOPHAGEAL REFLUX DISEASE 2240 0.0278
139 JUVENILE IDIOPATHIC ARTHRITIS 68 0.0278
140 PRODUCT LABEL CONFUSION 160 0.0274
141 RHEUMATOID NODULE 74 0.0268
142 PERICARDITIS 444 0.0264
143 ATELECTASIS 250 0.0258
144 LOSS OF EMPLOYMENT 78 0.0258
145 FIBROMYALGIA 620 0.0255
146 RECTAL CANCER 76 0.0247
147 LUNG OPACITY 65 0.0246
148 SYNOVIAL CYST 113 0.0244
149 SYNOVITIS 436 0.0242
150 ANTINUCLEAR ANTIBODY POSITIVE 77 0.0237
151 IMMUNODEFICIENCY 353 0.0237
152 BLOOD CREATININE DECREASED 74 0.0236
153 IRRITABLE BOWEL SYNDROME 498 0.0232
154 LOWER RESPIRATORY TRACT INFECTION 1050 0.0231
155 GASTROINTESTINAL STROMAL TUMOUR 59 0.0222
156 RHINALGIA 61 0.0222
157 ACUTE KIDNEY INJURY 3375 0.0220
158 GLOSSODYNIA 492 0.0220
159 RED BLOOD CELL COUNT INCREASED 59 0.0214
160 NEUTROPENIC SEPSIS 149 0.0208
161 LYMPHOPROLIFERATIVE DISORDER 61 0.0207
162 NEPHROPATHY 193 0.0207
163 PHARYNGITIS 256 0.0206
164 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 112 0.0206
165 PREMATURE LABOUR 116 0.0205
166 TASTE DISORDER 416 0.0205
167 CONTRAINDICATED PRODUCT ADMINISTERED 616 0.0203
168 FOOD INTOLERANCE 74 0.0202
169 RENAL FAILURE 2650 0.0199
170 CHOLECYSTITIS CHRONIC 133 0.0198
171 ANHEDONIA 521 0.0198
172 RALES 115 0.0198
173 TYPE 2 DIABETES MELLITUS 641 0.0190
174 LIVER FUNCTION TEST INCREASED 394 0.0183
175 REGURGITATION 62 0.0180
176 INFUSION SITE HAEMORRHAGE 59 0.0179
177 OSTEOARTHRITIS 750 0.0177
178 C-REACTIVE PROTEIN INCREASED 643 0.0177
179 BLOOD THYROID STIMULATING HORMONE DECREASED 80 0.0176
180 JOINT EFFUSION 120 0.0174
181 HIATUS HERNIA 224 0.0173
182 EPIGASTRIC DISCOMFORT 67 0.0171
183 HYPOMAGNESAEMIA 238 0.0171
184 RENAL CELL CARCINOMA 83 0.0169
185 NIGHT SWEATS 546 0.0169
186 NORMAL NEWBORN 92 0.0169
187 EPILEPSY 516 0.0169
188 BRAIN INJURY 169 0.0168
189 WOUND 471 0.0168
190 BLOOD PRESSURE INADEQUATELY CONTROLLED 101 0.0168
191 OESOPHAGITIS 182 0.0166
192 LIVER INJURY 408 0.0166
193 GAIT INABILITY 553 0.0165
194 MONOCYTE COUNT INCREASED 60 0.0165
195 RENAL TUBULAR NECROSIS 162 0.0165
196 KIDNEY TRANSPLANT REJECTION 79 0.0164
197 TENDERNESS 171 0.0164
198 PROTEIN URINE PRESENT 80 0.0160
199 NEUTROPHIL COUNT INCREASED 162 0.0158
200 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 80 0.0158
201 EXERCISE TOLERANCE DECREASED 90 0.0156
202 ATRIOVENTRICULAR BLOCK FIRST DEGREE 67 0.0154
203 WHEEZING 914 0.0154
204 ECONOMIC PROBLEM 233 0.0154
205 IMPAIRED HEALING 501 0.0152
206 BLOOD CHOLESTEROL INCREASED 708 0.0152
207 INFUSION RELATED REACTION 1001 0.0151
208 LUNG DISORDER 735 0.0150
209 HAEMATOCRIT DECREASED 296 0.0149
210 TOOTHACHE 270 0.0149
211 FOETAL DEATH 77 0.0148
212 SPUTUM DISCOLOURED 140 0.0147
213 PULSELESS ELECTRICAL ACTIVITY 61 0.0146
214 SPINAL OSTEOARTHRITIS 128 0.0146
215 BRONCHIECTASIS 98 0.0145
216 BLOOD PRESSURE SYSTOLIC INCREASED 282 0.0144
217 SQUAMOUS CELL CARCINOMA 136 0.0144
218 GASTRITIS 380 0.0144
219 BLOOD PRESSURE DIASTOLIC DECREASED 106 0.0143
220 COLITIS MICROSCOPIC 68 0.0143
221 HYPOPHOSPHATAEMIA 106 0.0143
222 BODY TEMPERATURE DECREASED 141 0.0143
223 ESCHERICHIA URINARY TRACT INFECTION 60 0.0141
224 MUSCULOSKELETAL PAIN 738 0.0141
225 ABNORMAL LOSS OF WEIGHT 96 0.0141
226 SYSTEMIC LUPUS ERYTHEMATOSUS 499 0.0140
227 UPPER RESPIRATORY TRACT INFECTION 648 0.0140
228 BLOOD PRESSURE DIASTOLIC INCREASED 64 0.0139
229 MOUTH SWELLING 80 0.0139
230 DRUG LEVEL INCREASED 229 0.0138
231 ADVERSE REACTION 182 0.0137
232 BLOOD URINE PRESENT 260 0.0137
233 MUCOSAL INFLAMMATION 355 0.0135
234 FLANK PAIN 127 0.0135
235 INFLAMMATION 695 0.0135
236 DYSLIPIDAEMIA 68 0.0134
237 BENIGN PROSTATIC HYPERPLASIA 68 0.0132
238 RENAL CYST 104 0.0131
239 PULSE ABSENT 62 0.0130
240 ANAPHYLACTIC REACTION 714 0.0129
241 OSTEOPENIA 195 0.0128
242 PNEUMONIA ASPIRATION 321 0.0128
243 HEPATIC ENZYME INCREASED 871 0.0128
244 OBSTRUCTIVE AIRWAYS DISORDER 142 0.0128
245 PSORIATIC ARTHROPATHY 516 0.0127
246 DYSPEPSIA 1244 0.0126
247 HEPATIC STEATOSIS 235 0.0126
248 VITAMIN D DEFICIENCY 122 0.0125
249 BODY TEMPERATURE INCREASED 254 0.0124
250 HEPATITIS 317 0.0124
251 VENTRICULAR FIBRILLATION 136 0.0122
252 DIVERTICULUM 87 0.0122
253 AFFECTIVE DISORDER 95 0.0121
254 BLISTER 677 0.0120
255 INTERVERTEBRAL DISC DEGENERATION 111 0.0120
256 RESPIRATORY RATE INCREASED 106 0.0119
257 BRONCHOSPASM 170 0.0119
258 SINUS BRADYCARDIA 115 0.0119
259 HYPOALBUMINAEMIA 92 0.0118
260 NECK PAIN 659 0.0118
261 DIABETIC NEUROPATHY 58 0.0117
262 CEREBRAL ISCHAEMIA 60 0.0116
263 ASPIRATION 126 0.0115
264 CONGENITAL ANOMALY 89 0.0115
265 ELECTROCARDIOGRAM QT PROLONGED 413 0.0115
266 HYPOAESTHESIA ORAL 173 0.0115
267 MYOCARDIAL ISCHAEMIA 129 0.0113
268 RENAL FAILURE CHRONIC 87 0.0113
269 POLYP 74 0.0113
270 TOXIC EPIDERMAL NECROLYSIS 171 0.0112
271 UPPER GASTROINTESTINAL HAEMORRHAGE 189 0.0112
272 NODULE 146 0.0112
273 EOSINOPHIL COUNT INCREASED 93 0.0111
274 BRADYCARDIA 591 0.0111
275 HAEMATEMESIS 282 0.0111
276 MALIGNANT MELANOMA 149 0.0111
277 PRE-EXISTING CONDITION IMPROVED 69 0.0110
278 PLATELET COUNT INCREASED 144 0.0110
279 CYSTIC FIBROSIS 61 0.0110
280 RASH ERYTHEMATOUS 525 0.0110
281 CARDIAC MURMUR 95 0.0110
282 INFUSION SITE EXTRAVASATION 68 0.0109
283 HYPONATRAEMIA 615 0.0109
284 DUODENAL ULCER 77 0.0109
285 STOMATITIS 661 0.0109
286 FOOT DEFORMITY 120 0.0108
287 RHINITIS 87 0.0108
288 INFUSION SITE PAIN 139 0.0108
289 CYANOSIS 169 0.0107
290 THERAPEUTIC PRODUCT EFFECT DECREASED 478 0.0107
291 ARTHROPATHY 592 0.0106
292 OSTEOPOROSIS 438 0.0106
293 ORAL CANDIDIASIS 140 0.0106
294 OXYGEN SATURATION DECREASED 596 0.0106
295 BLOOD CALCIUM INCREASED 93 0.0106
296 PARAESTHESIA ORAL 152 0.0105
297 DRY MOUTH 854 0.0105
298 MOBILITY DECREASED 753 0.0105
299 BLOOD ALBUMIN DECREASED 83 0.0105
300 SUPRAVENTRICULAR TACHYCARDIA 100 0.0104
301 BLOOD MAGNESIUM DECREASED 90 0.0104
302 SCIATICA 165 0.0103
303 PRESCRIBED OVERDOSE 200 0.0103
304 ACUTE PULMONARY OEDEMA 58 0.0103
305 ULCER 164 0.0103
306 RESPIRATORY DISTRESS 282 0.0102
307 PULMONARY FIBROSIS 196 0.0102
308 UROSEPSIS 94 0.0102
309 EXOSTOSIS 93 0.0102
310 DRUG-INDUCED LIVER INJURY 318 0.0101
311 WEIGHT FLUCTUATION 106 0.0101
312 ANAL INCONTINENCE 91 0.0101
313 LARYNGEAL OEDEMA 62 0.0101
314 HYPOXIA 354 0.0100
315 ACUTE CORONARY SYNDROME 83 0.0100
316 INFUSION SITE SWELLING 63 0.0100
317 BLOOD PRESSURE FLUCTUATION 240 0.0100
318 HYPOKALAEMIA 461 0.0100
319 FACIAL PARALYSIS 85 0.0100
320 ANGIOEDEMA 437 0.0099
321 HYPERLIPIDAEMIA 118 0.0099
322 RESPIRATORY DEPRESSION 121 0.0099
323 PULMONARY MASS 147 0.0099
324 INTERNATIONAL NORMALISED RATIO INCREASED 281 0.0098
325 EAR PAIN 191 0.0098
326 HYPERTENSION 2081 0.0098
327 TORSADE DE POINTES 77 0.0098
328 PIGMENTATION DISORDER 60 0.0097
329 ABDOMINAL PAIN UPPER 2000 0.0097
330 LEFT VENTRICULAR DYSFUNCTION 65 0.0097
331 GALLBLADDER DISORDER 173 0.0097
332 MUSCULOSKELETAL STIFFNESS 848 0.0097
333 HYPOAESTHESIA 1448 0.0097
334 POOR VENOUS ACCESS 100 0.0097
335 SLEEP APNOEA SYNDROME 184 0.0096
336 DRUG INTOLERANCE 929 0.0096
337 PETECHIAE 100 0.0096
338 SCREAMING 61 0.0096
339 HYPOCALCAEMIA 181 0.0096
340 SWELLING 892 0.0095
341 BREAST MASS 64 0.0095
342 SOMNAMBULISM 62 0.0094
343 BLOOD UREA INCREASED 158 0.0094
344 CHOLELITHIASIS 309 0.0094
345 HEMIPARESIS 159 0.0094
346 GASTRIC ULCER 178 0.0094
347 BLOOD THYROID STIMULATING HORMONE INCREASED 86 0.0093
348 PULMONARY TOXICITY 66 0.0093
349 RHEUMATOID ARTHRITIS 1058 0.0093
350 SWOLLEN TONGUE 291 0.0093
351 APHTHOUS ULCER 72 0.0093
352 CARDIOMEGALY 114 0.0093
353 TACHYCARDIA 823 0.0093
354 RENAL FAILURE ACUTE 393 0.0093
355 AUTOIMMUNE DISORDER 90 0.0092
356 MIGRAINE 876 0.0092
357 BONE DISORDER 167 0.0092
358 ULCER HAEMORRHAGE 62 0.0092
359 CIRCULATORY COLLAPSE 156 0.0092
360 CONFUSIONAL STATE 1480 0.0091
361 URTICARIA 1534 0.0091
362 PLASMA CELL MYELOMA 357 0.0091
363 BLOOD CREATININE INCREASED 597 0.0091
364 SEASONAL ALLERGY 129 0.0091
365 DIABETES MELLITUS INADEQUATE CONTROL 161 0.0091
366 HEART RATE DECREASED 319 0.0091
367 FEBRILE NEUTROPENIA 602 0.0091
368 LOWER GASTROINTESTINAL HAEMORRHAGE 67 0.0091
369 SCHIZOPHRENIA 110 0.0090
370 URINE OUTPUT DECREASED 79 0.0090
371 ATRIAL FLUTTER 72 0.0090
372 HAEMORRHOIDS 176 0.0090
373 EXPOSURE DURING PREGNANCY 559 0.0090
374 FLUID RETENTION 457 0.0090
375 PERIPHERAL COLDNESS 123 0.0089
376 POST-TRAUMATIC STRESS DISORDER 60 0.0089
377 WALKING AID USER 59 0.0089
378 SINUS TACHYCARDIA 127 0.0089
379 PSYCHOLOGICAL TRAUMA 77 0.0089
380 MUSCULAR WEAKNESS 1012 0.0089
381 LIVER FUNCTION TEST ABNORMAL 258 0.0089
382 HEREDITARY ANGIOEDEMA 95 0.0088
383 RED BLOOD CELL COUNT DECREASED 253 0.0088
384 JOINT SWELLING 1068 0.0088
385 HAEMOPTYSIS 246 0.0088
386 OPTIC NEURITIS 80 0.0088
387 ASTHMA 994 0.0088
388 INTENTIONAL PRODUCT USE ISSUE 768 0.0088
389 BLADDER DISORDER 87 0.0088
390 ABDOMINAL DISTENSION 914 0.0087
391 APHONIA 122 0.0087
392 CONJUNCTIVITIS 162 0.0087
393 HEART RATE IRREGULAR 197 0.0087
394 HYPOTONIA 87 0.0087
395 INCONTINENCE 92 0.0087
396 HAEMOGLOBIN DECREASED 892 0.0087
397 CONTUSION 836 0.0087
398 FLUSHING 881 0.0087
399 VENTRICULAR TACHYCARDIA 143 0.0087
400 CHEST DISCOMFORT 883 0.0086
401 EJECTION FRACTION DECREASED 134 0.0086
402 LEUKOCYTOSIS 156 0.0086
403 PARAESTHESIA 1355 0.0086
404 ATAXIA 102 0.0086
405 SLEEP DISORDER 606 0.0086
406 PHARYNGEAL OEDEMA 132 0.0086
407 CHOLECYSTECTOMY 98 0.0086
408 HEPATOMEGALY 84 0.0085
409 TACHYPNOEA 116 0.0085
410 POOR QUALITY SLEEP 183 0.0085
411 PERIPHERAL SWELLING 1309 0.0085
412 RASH MACULO-PAPULAR 189 0.0085
413 FAECES DISCOLOURED 183 0.0084
414 LEUKOPENIA 422 0.0084
415 HYDRONEPHROSIS 63 0.0084
416 ABDOMINAL PAIN 1951 0.0084
417 PHARYNGEAL SWELLING 82 0.0084
418 INTERVERTEBRAL DISC PROTRUSION 183 0.0084
419 DRUG SCREEN POSITIVE 66 0.0083
420 LIP SWELLING 278 0.0083
421 IRON DEFICIENCY ANAEMIA 77 0.0083
422 DRUG INTERACTION 1323 0.0083
423 SENSORY LOSS 67 0.0083
424 BODY HEIGHT DECREASED 89 0.0083
425 FEELING HOT 509 0.0083
426 OEDEMA PERIPHERAL 1010 0.0083
427 ABDOMINAL DISCOMFORT 1386 0.0083
428 PAIN IN JAW 233 0.0082
429 APNOEA 64 0.0082
430 HYPOPHAGIA 210 0.0082
431 MOUTH ULCERATION 173 0.0082
432 HAEMATURIA 280 0.0082
433 NEUTROPHIL COUNT DECREASED 333 0.0082
434 BRAIN NEOPLASM 75 0.0082
435 CHEST PAIN 1511 0.0081
436 CELLULITIS 411 0.0081
437 CHOLECYSTITIS 97 0.0081
438 MYOSITIS 73 0.0081
439 ACUTE MYOCARDIAL INFARCTION 239 0.0081
440 PULMONARY CONGESTION 106 0.0080
441 TROPONIN INCREASED 61 0.0080
442 BLOOD TEST ABNORMAL 112 0.0080
443 GOUT 143 0.0080
444 WHITE BLOOD CELL COUNT INCREASED 305 0.0079
445 CANDIDA INFECTION 134 0.0079
446 TRICUSPID VALVE INCOMPETENCE 63 0.0079
447 RESTLESS LEGS SYNDROME 144 0.0079
448 ALANINE AMINOTRANSFERASE INCREASED 485 0.0079
449 URINARY INCONTINENCE 234 0.0079
450 JAUNDICE 212 0.0079
451 DEPRESSION 1791 0.0079
452 BLOOD DISORDER 63 0.0079
453 JOINT DISLOCATION 83 0.0078
454 ACUTE RESPIRATORY FAILURE 151 0.0078
455 CLOSTRIDIUM DIFFICILE INFECTION 171 0.0078
456 ELECTROLYTE IMBALANCE 91 0.0078
457 INFUSION SITE ERYTHEMA 66 0.0078
458 SMALL INTESTINAL OBSTRUCTION 96 0.0078
459 GASTRIC DISORDER 267 0.0078
460 BASAL CELL CARCINOMA 121 0.0077
461 GASTROENTERITIS 113 0.0077
462 PLEURAL EFFUSION 471 0.0077
463 EMPHYSEMA 78 0.0077
464 BLOOD ALKALINE PHOSPHATASE INCREASED 192 0.0077
465 GASTROINTESTINAL DISORDER 690 0.0077
466 SINUS CONGESTION 104 0.0077
467 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 79 0.0077
468 HYPERSENSITIVITY 1428 0.0077
469 FEELING COLD 214 0.0077
470 GAMMA-GLUTAMYLTRANSFERASE INCREASED 170 0.0077
471 MULTIPLE FRACTURES 126 0.0077
472 LIMB DISCOMFORT 237 0.0077
473 DECUBITUS ULCER 62 0.0076
474 BACK PAIN 1765 0.0076
475 LUNG INFECTION 118 0.0076
476 HEART RATE INCREASED 752 0.0076
477 LUNG INFILTRATION 67 0.0076
478 SKIN INFECTION 85 0.0076
479 CARPAL TUNNEL SYNDROME 106 0.0076
480 PANCREATITIS ACUTE 170 0.0076
481 HYPERGLYCAEMIA 275 0.0075
482 HYPERHIDROSIS 972 0.0075
483 SKIN ULCER 195 0.0075
484 BIPOLAR DISORDER 82 0.0075
485 THROAT TIGHTNESS 204 0.0075
486 PULMONARY HYPERTENSION 157 0.0075
487 MUSCLE TIGHTNESS 122 0.0075
488 HYPERKALAEMIA 264 0.0075
489 OROPHARYNGEAL DISCOMFORT 68 0.0075
490 RECTAL HAEMORRHAGE 323 0.0075
491 PNEUMONIA 2430 0.0075
492 ERYTHEMA MULTIFORME 70 0.0075
493 HAEMODIALYSIS 63 0.0075
494 PRODUCTIVE COUGH 358 0.0075
495 VITAMIN D DECREASED 64 0.0075
496 PRESYNCOPE 182 0.0075
497 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 58 0.0075
498 TEMPERATURE INTOLERANCE 77 0.0075
499 MUSCULOSKELETAL CHEST PAIN 115 0.0074
500 CORONARY ARTERY DISEASE 224 0.0074
501 BONE DENSITY DECREASED 231 0.0074
502 MATERNAL EXPOSURE DURING PREGNANCY 657 0.0074
503 ERUCTATION 142 0.0073
504 CONSTIPATION 1600 0.0073
505 STEVENS-JOHNSON SYNDROME 163 0.0073
506 BLOOD BILIRUBIN INCREASED 198 0.0073
507 DELIRIUM 254 0.0073
508 LETHARGY 421 0.0073
509 OCULAR DISCOMFORT 82 0.0073
510 HYPOTENSION 1462 0.0073
511 NERVE INJURY 81 0.0073
512 VOMITING 3419 0.0073
513 CHROMATURIA 164 0.0073
514 NERVE COMPRESSION 67 0.0073
515 HYPERBILIRUBINAEMIA 75 0.0072
516 DECREASED IMMUNE RESPONSIVENESS 71 0.0072
517 ILL-DEFINED DISORDER 439 0.0072
518 DIZZINESS POSTURAL 70 0.0072
519 GENERAL PHYSICAL HEALTH DETERIORATION 835 0.0072
520 PRURITUS GENERALISED 156 0.0072
521 PROTEINURIA 137 0.0072
522 SWELLING FACE 468 0.0072
523 CLOSTRIDIUM DIFFICILE COLITIS 76 0.0072
524 FOOT FRACTURE 135 0.0071
525 MULTI-ORGAN FAILURE 123 0.0071
526 SKIN PLAQUE 60 0.0071
527 MEMORY IMPAIRMENT 976 0.0071
528 ORAL PAIN 159 0.0071
529 ANXIETY 2019 0.0071
530 MICTURITION URGENCY 81 0.0071
531 BLOOD POTASSIUM INCREASED 115 0.0071
532 MUSCLE SPASMS 1294 0.0070
533 FEELING JITTERY 134 0.0070
534 SINUSITIS 720 0.0070
535 THROMBOCYTOPENIA 784 0.0070
536 PURPURA 62 0.0070
537 SKIN LACERATION 76 0.0070
538 BRONCHITIS 517 0.0070
539 ANKLE FRACTURE 108 0.0070
540 JOINT STIFFNESS 183 0.0070
541 TRANSFUSION 73 0.0070
542 COAGULOPATHY 116 0.0070
543 DYSPNOEA 3940 0.0070
544 MELAENA 153 0.0069
545 MENTAL STATUS CHANGES 193 0.0069
546 COUGH 1947 0.0069
547 NASOPHARYNGITIS 1277 0.0069
548 RESPIRATORY FAILURE 505 0.0069
549 HALLUCINATION, AUDITORY 110 0.0069
550 NOCTURIA 84 0.0069
551 RENAL IMPAIRMENT 581 0.0069
552 BLOOD IRON DECREASED 82 0.0069
553 ASTHENIA 2598 0.0069
554 MALNUTRITION 77 0.0069
555 DISABILITY 136 0.0069
556 DYSURIA 253 0.0069
557 CAESAREAN SECTION 80 0.0069
558 ERYTHEMA 1411 0.0069
559 RETCHING 146 0.0068
560 PREMATURE BABY 206 0.0068
561 BLOOD SODIUM DECREASED 129 0.0068
562 PAIN IN EXTREMITY 2013 0.0068
563 MITRAL VALVE INCOMPETENCE 77 0.0068
564 CORONARY ARTERY OCCLUSION 93 0.0068
565 ORTHOSTATIC HYPOTENSION 118 0.0068
566 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 353 0.0068
567 HYPOTHYROIDISM 216 0.0068
568 AMNESIA 440 0.0068
569 GLOMERULAR FILTRATION RATE DECREASED 83 0.0067
570 PHOTOPHOBIA 127 0.0067
571 TRANSAMINASES INCREASED 150 0.0067
572 BACTERAEMIA 80 0.0067
573 BLOOD POTASSIUM DECREASED 202 0.0067
574 DYSPNOEA EXERTIONAL 253 0.0067
575 FLATULENCE 380 0.0067
576 IMPAIRED WORK ABILITY 143 0.0067
577 THYROID DISORDER 103 0.0067
578 COGNITIVE DISORDER 312 0.0067
579 TOOTH ABSCESS 68 0.0067
580 DERMATITIS ALLERGIC 84 0.0067
581 NEUROPATHY PERIPHERAL 635 0.0067
582 PLATELET COUNT DECREASED 711 0.0067
583 SEPSIS 744 0.0067
584 CHOKING 130 0.0067
585 DIPLOPIA 173 0.0067
586 OROPHARYNGEAL PAIN 616 0.0066
587 EAR INFECTION 177 0.0066
588 BACK DISORDER 108 0.0066
589 THROAT IRRITATION 298 0.0066
590 DIVERTICULITIS 184 0.0066
591 ARTHRALGIA 2758 0.0066
592 CYSTITIS 211 0.0066
593 FREQUENT BOWEL MOVEMENTS 179 0.0066
594 CARDIAC ARREST 547 0.0066
595 CARDIOGENIC SHOCK 95 0.0066
596 DYSSTASIA 193 0.0066
597 RENAL PAIN 70 0.0066
598 PYREXIA 2282 0.0066
599 ANAPHYLACTIC SHOCK 170 0.0066
600 LIVER DISORDER 292 0.0066
601 GASTROINTESTINAL HAEMORRHAGE 549 0.0066
602 DYSPHONIA 384 0.0066
603 PANCREATITIS 346 0.0065
604 DEHYDRATION 873 0.0065
605 HYPOKINESIA 95 0.0065
606 RESPIRATORY TRACT INFECTION 170 0.0065
607 RIB FRACTURE 134 0.0065
608 UNRESPONSIVE TO STIMULI 168 0.0065
609 PNEUMOTHORAX 103 0.0065
610 ARTERIOSCLEROSIS 61 0.0065
611 EATING DISORDER 138 0.0065
612 GASTROENTERITIS VIRAL 117 0.0065
613 COMA 308 0.0065
614 ANAEMIA 1233 0.0065
615 DIABETES MELLITUS 492 0.0064
616 NEPHROLITHIASIS 296 0.0064
617 VENTRICULAR EXTRASYSTOLES 67 0.0064
618 URINARY TRACT INFECTION 1100 0.0064
619 ILEUS 80 0.0064
620 BLOOD PRESSURE INCREASED 984 0.0064
621 BLOOD TRIGLYCERIDES INCREASED 113 0.0064
622 INSOMNIA 1703 0.0064
623 EYE INFLAMMATION 61 0.0064
624 PAIN 3921 0.0064
625 DYSARTHRIA 240 0.0064
626 MASS 89 0.0064
627 HEADACHE 3977 0.0063
628 PALLOR 172 0.0063
629 SEPTIC SHOCK 275 0.0063
630 SPINAL PAIN 74 0.0063
631 ARTHRITIS 496 0.0063
632 RASH GENERALISED 163 0.0063
633 DISCOMFORT 384 0.0063
634 DYSPHAGIA 597 0.0063
635 VIRAL INFECTION 209 0.0063
636 JOINT INJURY 134 0.0063
637 URINARY RETENTION 209 0.0063
638 QUALITY OF LIFE DECREASED 84 0.0063
639 NEURALGIA 152 0.0062
640 EPISTAXIS 467 0.0062
641 HEPATOTOXICITY 139 0.0062
642 ASPARTATE AMINOTRANSFERASE INCREASED 331 0.0062
643 RESTLESSNESS 228 0.0062
644 SPINAL DISORDER 59 0.0062
645 HEPATIC CIRRHOSIS 117 0.0062
646 GINGIVAL BLEEDING 85 0.0062
647 RASH PRURITIC 337 0.0062
648 PNEUMONITIS 169 0.0062
649 TOOTH DISORDER 138 0.0062
650 MYOCLONUS 74 0.0062
651 TREMOR 1028 0.0062
652 BLOOD LACTATE DEHYDROGENASE INCREASED 98 0.0062
653 ANGINA PECTORIS 177 0.0062
654 WEIGHT DECREASED 1723 0.0062
655 NEUTROPENIA 838 0.0062
656 ACUTE RESPIRATORY DISTRESS SYNDROME 109 0.0062
657 OEDEMA 334 0.0062
658 CONDITION AGGRAVATED 1869 0.0061
659 RED BLOOD CELL SEDIMENTATION RATE INCREASED 68 0.0061
660 PULMONARY OEDEMA 275 0.0061
661 DECREASED APPETITE 1426 0.0061
662 MALAISE 2692 0.0061
663 ALOPECIA 1205 0.0061
664 ANOREXIA 79 0.0061
665 EMOTIONAL DISTRESS 741 0.0061
666 TREATMENT FAILURE 506 0.0061
667 HAIR COLOUR CHANGES 76 0.0061
668 METASTASES TO BONE 100 0.0061
669 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1098 0.0061
670 WHITE BLOOD CELL COUNT DECREASED 659 0.0061
671 WEIGHT INCREASED 1361 0.0061
672 GLAUCOMA 117 0.0061
673 KIDNEY INFECTION 119 0.0061
674 DIARRHOEA 3913 0.0061
675 SINUS DISORDER 120 0.0061
676 FLUID OVERLOAD 88 0.0060
677 CHILLS 707 0.0060
678 DIZZINESS 3006 0.0060
679 OSTEOMYELITIS 109 0.0060
680 NAUSEA 4761 0.0060
681 LYMPHOPENIA 85 0.0060
682 ATRIAL FIBRILLATION 583 0.0060
683 PRODUCT USE IN UNAPPROVED INDICATION 1483 0.0060
684 DEVICE RELATED INFECTION 92 0.0060
685 LIGAMENT SPRAIN 59 0.0060
686 CYST 74 0.0060
687 TRANSIENT ISCHAEMIC ATTACK 201 0.0060
688 ROAD TRAFFIC ACCIDENT 249 0.0059
689 PULMONARY EMBOLISM 565 0.0059
690 EYE INFECTION 67 0.0059
691 FACE OEDEMA 100 0.0059
692 CARDIAC FAILURE CONGESTIVE 476 0.0059
693 WRIST FRACTURE 71 0.0059
694 HYPERCALCAEMIA 73 0.0059
695 SARS-COV-2 TEST POSITIVE 78 0.0059
696 BLOOD PRESSURE DECREASED 392 0.0059
697 HERNIA 114 0.0059
698 DENTAL CARIES 65 0.0059
699 SKIN LESION 161 0.0059
700 LOCAL SWELLING 102 0.0058
701 SYNCOPE 585 0.0058
702 POLYNEUROPATHY 70 0.0058
703 EAR DISCOMFORT 60 0.0058
704 TOOTH INFECTION 77 0.0058
705 SPEECH DISORDER 306 0.0058
706 FUNGAL INFECTION 194 0.0058
707 PRODUCT USE ISSUE 1093 0.0058
708 EMOTIONAL DISORDER 179 0.0058
709 PARALYSIS 83 0.0058
710 FATIGUE 4504 0.0058
711 BALANCE DISORDER 500 0.0058
712 HALLUCINATION, VISUAL 122 0.0058
713 FALL 1915 0.0057
714 MUSCULOSKELETAL DISCOMFORT 99 0.0057
715 LIMB INJURY 156 0.0057
716 LOSS OF CONSCIOUSNESS 735 0.0057
717 BACTERIAL INFECTION 107 0.0057
718 STAPHYLOCOCCAL INFECTION 189 0.0057
719 GASTROINTESTINAL PAIN 63 0.0057
720 LOWER LIMB FRACTURE 110 0.0057
721 METABOLIC ACIDOSIS 183 0.0057
722 NEUROTOXICITY 100 0.0057
723 BONE PAIN 334 0.0057
724 RASH 2473 0.0057
725 OCULAR HYPERAEMIA 268 0.0056
726 CARDIO-RESPIRATORY ARREST 236 0.0056
727 SOMNOLENCE 1136 0.0056
728 DISORIENTATION 223 0.0056
729 BREAST PAIN 60 0.0056
730 COLD SWEAT 99 0.0056
731 RASH MACULAR 196 0.0056
732 COLITIS 212 0.0056
733 SECRETION DISCHARGE 70 0.0056
734 HEPATIC FAILURE 168 0.0056
735 DECREASED ACTIVITY 60 0.0056
736 PSYCHOTIC DISORDER 164 0.0055
737 SPLENOMEGALY 65 0.0055
738 ROTATOR CUFF SYNDROME 71 0.0055
739 NEPHROPATHY TOXIC 62 0.0055
740 HAEMATOMA 143 0.0055
741 RESPIRATORY DISORDER 165 0.0055
742 RENAL DISORDER 256 0.0055
743 SENSORY DISTURBANCE 88 0.0055
744 POST PROCEDURAL COMPLICATION 105 0.0055
745 DYSGEUSIA 406 0.0055
746 LYMPHADENOPATHY 193 0.0054
747 ASCITES 160 0.0054
748 RHINORRHOEA 351 0.0054
749 IMPAIRED GASTRIC EMPTYING 74 0.0054
750 FEEDING DISORDER 110 0.0054
751 HALLUCINATION 408 0.0054
752 TOOTH LOSS 112 0.0054
753 POLLAKIURIA 225 0.0054
754 PANCYTOPENIA 301 0.0054
755 PRODUCT QUALITY ISSUE 731 0.0054
756 DRUG TOXICITY 73 0.0054
757 PRURITUS 2047 0.0053
758 BURNING SENSATION 373 0.0053
759 CATARACT 316 0.0053
760 BRAIN OEDEMA 67 0.0053
761 HYPOGLYCAEMIA 257 0.0053
762 METASTASES TO LIVER 93 0.0053
763 SKIN DISCOLOURATION 243 0.0053
764 INTESTINAL PERFORATION 59 0.0053
765 PRODUCT PRESCRIBING ERROR 125 0.0052
766 BLOOD CALCIUM DECREASED 59 0.0052
767 SEIZURE 606 0.0052
768 NERVOUSNESS 274 0.0052
769 RESPIRATORY TRACT CONGESTION 83 0.0052
770 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 371 0.0052
771 BLOOD COUNT ABNORMAL 79 0.0052
772 HAEMATOCHEZIA 287 0.0052
773 PARANOIA 89 0.0052
774 EXTRAPYRAMIDAL DISORDER 128 0.0051
775 SEROTONIN SYNDROME 99 0.0051
776 BONE MARROW FAILURE 104 0.0051
777 MYALGIA 866 0.0051
778 HYPERSOMNIA 146 0.0051
779 NASAL CONGESTION 299 0.0051
780 INFLUENZA 567 0.0051
781 HAIR TEXTURE ABNORMAL 68 0.0051
782 HERPES ZOSTER 292 0.0051
783 AGITATION 373 0.0051
784 IMPAIRED QUALITY OF LIFE 73 0.0051
785 ABSCESS 81 0.0051
786 MEDICATION ERROR 282 0.0051
787 GAIT DISTURBANCE 971 0.0051
788 ORAL HERPES 99 0.0051
789 UPPER LIMB FRACTURE 101 0.0051
790 PERICARDIAL EFFUSION 117 0.0051
791 HEAD INJURY 160 0.0051
792 HYPERTHYROIDISM 73 0.0050
793 RHABDOMYOLYSIS 210 0.0050
794 SUBDURAL HAEMATOMA 72 0.0050
795 SCAR 86 0.0050
796 EOSINOPHILIA 88 0.0050
797 MOVEMENT DISORDER 161 0.0050
798 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 129 0.0050
799 IMMUNE SYSTEM DISORDER 66 0.0050
800 BLOOD PRESSURE ABNORMAL 99 0.0050
801 SKIN DISORDER 166 0.0050
802 DEPRESSED MOOD 263 0.0050
803 RESPIRATORY ARREST 137 0.0050
804 DRY EYE 248 0.0050
805 BLOOD CREATINE PHOSPHOKINASE INCREASED 143 0.0050
806 DERMATITIS 104 0.0050
807 INFECTION 718 0.0050
808 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 85 0.0050
809 DEEP VEIN THROMBOSIS 322 0.0050
810 APHASIA 149 0.0049
811 VISION BLURRED 677 0.0049
812 PALPITATIONS 574 0.0049
813 INTESTINAL OBSTRUCTION 184 0.0049
814 DYSKINESIA 197 0.0048
815 DEPRESSED LEVEL OF CONSCIOUSNESS 191 0.0048
816 CONVULSION 276 0.0048
817 THROMBOSIS 388 0.0048
818 INTENTIONAL PRODUCT MISUSE 422 0.0048
819 HAEMORRHAGE INTRACRANIAL 72 0.0048
820 SNEEZING 108 0.0048
821 EYE PAIN 271 0.0048
822 PHOTOSENSITIVITY REACTION 79 0.0048
823 MUSCLE TWITCHING 110 0.0048
824 CRYING 173 0.0048
825 MULTIPLE SCLEROSIS RELAPSE 326 0.0048
826 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 228 0.0047
827 FEELING ABNORMAL 1135 0.0047
828 RASH PAPULAR 106 0.0047
829 ACTIVITIES OF DAILY LIVING IMPAIRED 93 0.0047
830 SEDATION 122 0.0047
831 ARRHYTHMIA 220 0.0046
832 THIRST 83 0.0046
833 INJECTION SITE REACTION 319 0.0046
834 LOCALISED INFECTION 112 0.0046
835 MENTAL DISORDER 201 0.0046
836 MOOD SWINGS 147 0.0046
837 TREATMENT NONCOMPLIANCE 252 0.0046
838 HOT FLUSH 346 0.0046
839 LACRIMATION INCREASED 138 0.0046
840 MANIA 75 0.0046
841 VERTIGO 277 0.0045
842 ORAL DISCOMFORT 63 0.0045
843 TENDONITIS 70 0.0045
844 ENCEPHALOPATHY 111 0.0045
845 HEAD DISCOMFORT 80 0.0045
846 CYTOMEGALOVIRUS INFECTION 75 0.0045
847 LABORATORY TEST ABNORMAL 133 0.0045
848 BEDRIDDEN 59 0.0045
849 NERVOUS SYSTEM DISORDER 140 0.0045
850 TARDIVE DYSKINESIA 126 0.0045
851 ERECTILE DYSFUNCTION 114 0.0044
852 HIP FRACTURE 141 0.0044
853 CARDIOVASCULAR DISORDER 111 0.0044
854 DISTURBANCE IN ATTENTION 234 0.0043
855 NIGHTMARE 150 0.0043
856 CARDIOMYOPATHY 64 0.0043
857 CARDIAC FAILURE 347 0.0043
858 PERITONITIS 89 0.0043
859 ABASIA 106 0.0043
860 MIDDLE INSOMNIA 80 0.0043
861 PSYCHOMOTOR HYPERACTIVITY 71 0.0043
862 DIALYSIS 60 0.0042
863 EYE SWELLING 157 0.0042
864 FOETAL EXPOSURE DURING PREGNANCY 342 0.0042
865 DRUG EXPOSURE DURING PREGNANCY 143 0.0042
866 PANIC ATTACK 152 0.0042
867 ANGER 141 0.0042
868 INTERSTITIAL LUNG DISEASE 201 0.0041
869 VISUAL IMPAIRMENT 514 0.0041
870 INFLUENZA LIKE ILLNESS 341 0.0041
871 TINNITUS 190 0.0041
872 OSTEONECROSIS OF JAW 102 0.0041
873 KNEE ARTHROPLASTY 86 0.0041
874 MENTAL IMPAIRMENT 99 0.0041
875 CEREBRAL HAEMORRHAGE 146 0.0041
876 PULMONARY ARTERIAL HYPERTENSION 59 0.0041
877 FEAR 109 0.0040
878 FEMUR FRACTURE 125 0.0040
879 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 94 0.0040
880 PRODUCT DOSE OMISSION 263 0.0040
881 UNDERDOSE 294 0.0040
882 MULTIPLE ORGAN DYSFUNCTION SYNDROME 114 0.0040
883 DRUG PRESCRIBING ERROR 77 0.0040
884 HIP ARTHROPLASTY 61 0.0040
885 IRRITABILITY 238 0.0040
886 ABDOMINAL PAIN LOWER 100 0.0040
887 OFF LABEL USE 3447 0.0039
888 DEMENTIA 110 0.0039
889 ABNORMAL DREAMS 108 0.0039
890 PELVIC PAIN 71 0.0039
891 MYOCARDIAL INFARCTION 668 0.0038
892 SUICIDAL IDEATION 348 0.0038
893 BREAST CANCER FEMALE 101 0.0038
894 CHOLESTASIS 72 0.0037
895 DISEASE PROGRESSION 443 0.0037
896 AGRANULOCYTOSIS 69 0.0037
897 PRESCRIBED UNDERDOSE 74 0.0037
898 BLOOD GLUCOSE DECREASED 178 0.0037
899 DRUG DOSE OMISSION 598 0.0036
900 DRUG EFFECT DECREASED 194 0.0036
901 INCORRECT PRODUCT ADMINISTRATION DURATION 78 0.0036
902 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 61 0.0036
903 SHOCK 82 0.0036
904 AGGRESSION 176 0.0035
905 CARDIAC DISORDER 328 0.0035
906 ISCHAEMIC STROKE 62 0.0035
907 ABNORMAL BEHAVIOUR 137 0.0035
908 HAEMORRHAGE 361 0.0034
909 VISUAL ACUITY REDUCED 114 0.0034
910 PSORIASIS 448 0.0034
911 HEPATIC FUNCTION ABNORMAL 128 0.0034
912 CEREBROVASCULAR ACCIDENT 579 0.0034
913 NEOPLASM PROGRESSION 118 0.0034
914 PHARMACEUTICAL PRODUCT COMPLAINT 88 0.0034
915 FRACTURE 64 0.0034
916 ECZEMA 176 0.0034
917 MUSCULOSKELETAL DISORDER 64 0.0034
918 THERAPY NON-RESPONDER 151 0.0034
919 ADVERSE DRUG REACTION 301 0.0033
920 WITHDRAWAL SYNDROME 140 0.0033
921 COLITIS ULCERATIVE 148 0.0033
922 PREGNANCY 66 0.0033
923 FULL BLOOD COUNT DECREASED 66 0.0033
924 DEAFNESS 85 0.0032
925 DYSTONIA 63 0.0032
926 PROCEDURAL PAIN 90 0.0032
927 UNEVALUABLE EVENT 245 0.0032
928 SPINAL FRACTURE 64 0.0032
929 WRONG TECHNIQUE IN DRUG USAGE PROCESS 116 0.0032
930 MOOD ALTERED 87 0.0032
931 THERAPEUTIC RESPONSE UNEXPECTED 142 0.0032
932 EXPIRED PRODUCT ADMINISTERED 104 0.0031
933 DRUG INEFFECTIVE 4120 0.0031
934 DIABETIC KETOACIDOSIS 73 0.0030
935 ADVERSE EVENT 278 0.0030
936 OVERDOSE 649 0.0030
937 EYE PRURITUS 101 0.0030
938 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 211 0.0030
939 DRUG EFFECT INCOMPLETE 107 0.0029
940 TOXICITY TO VARIOUS AGENTS 495 0.0029
941 INCORRECT DRUG ADMINISTRATION DURATION 82 0.0029
942 DRUG ADMINISTRATION ERROR 89 0.0029
943 OSTEONECROSIS 95 0.0029
944 EYE DISORDER 95 0.0029
945 MALIGNANT NEOPLASM PROGRESSION 293 0.0029
946 PRODUCT SUBSTITUTION ISSUE 164 0.0028
947 SURGERY 165 0.0028
948 BLOOD GLUCOSE INCREASED 529 0.0028
949 AGEUSIA 70 0.0028
950 HYPOACUSIS 120 0.0028
951 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 152 0.0028
952 ACCIDENTAL OVERDOSE 100 0.0027
953 EYE IRRITATION 154 0.0027
954 MULTIPLE SCLEROSIS 126 0.0026
955 DEATH 2266 0.0026
956 BLINDNESS 107 0.0026
957 LACTIC ACIDOSIS 85 0.0026
958 CEREBRAL INFARCTION 63 0.0026
959 THERAPEUTIC RESPONSE DECREASED 154 0.0025
960 PAIN OF SKIN 68 0.0025
961 THERAPY CESSATION 129 0.0025
962 SKIN EXFOLIATION 209 0.0025
963 HOSPITALISATION 377 0.0025
964 INTENTIONAL OVERDOSE 156 0.0024
965 INJECTION SITE BRUISING 192 0.0024
966 INJECTION SITE MASS 88 0.0024
967 GLYCOSYLATED HAEMOGLOBIN INCREASED 59 0.0023
968 SUICIDE ATTEMPT 138 0.0023
969 COMPLETED SUICIDE 186 0.0022
970 INJECTION SITE SWELLING 170 0.0022
971 DRY SKIN 294 0.0022
972 VAGINAL HAEMORRHAGE 92 0.0021
973 ILLNESS 216 0.0021
974 DISEASE RECURRENCE 99 0.0021
975 SKIN BURNING SENSATION 146 0.0020
976 ACNE 150 0.0020
977 EXTRA DOSE ADMINISTERED 80 0.0020
978 INJECTION SITE ERYTHEMA 221 0.0018
979 DRUG ABUSE 147 0.0018
980 INJECTION SITE PRURITUS 117 0.0017
981 COVID-19 302 0.0017
982 DRUG WITHDRAWAL SYNDROME 139 0.0016
983 INJECTION SITE PAIN 483 0.0016
984 ABORTION SPONTANEOUS 63 0.0016
985 INJECTION SITE HAEMORRHAGE 123 0.0015
986 DEVICE ISSUE 120 0.0013
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 265 0.0013
988 DRUG DEPENDENCE 210 0.0013
989 NO ADVERSE EVENT 231 0.0013
990 PRODUCT DOSE OMISSION ISSUE 349 0.0012
991 DEVICE MALFUNCTION 81 0.0012